Commonwealth Equity Services’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $955K | Sell |
|
|||||
|
2025
Q2 | $1.05M | Buy |
|
|||||
|
2025
Q1 | $958K | Buy |
|
|||||
|
2024
Q4 | $1.1M | Buy |
|
|||||
|
2024
Q3 | $542K | Buy |
|
|||||
|
2024
Q2 | $399K | Buy |
|
|||||
|
2024
Q1 | $476K | Buy |
|
|||||
|
2023
Q4 | $855K | Buy |
|
|||||
|
2023
Q3 | $545K | Sell |
|
|||||
|
2023
Q2 | $715K | Buy |
|
|||||
|
2023
Q1 | $752 | Sell |
|
|||||
|
2022
Q4 | $842K | Buy |
|
|||||
|
2022
Q3 | $850K | Buy |
|
|||||
|
2022
Q2 | $821K | Buy |
|
|||||
|
2022
Q1 | $982K | Buy |
|
|||||
|
2021
Q4 | $1.29M | Buy |
|
|||||
|
2021
Q3 | $759K | Buy |
|
|||||
|
2021
Q2 | $954K | Buy |
|
|||||
|
2021
Q1 | $559K | Sell |
|
|||||
|
2020
Q4 | $237K | Buy |
|
|||||
|
2020
Q3 | $146K | Buy |
|
|||||
|
2020
Q2 | $156K | Sell |
|
|||||
|
2020
Q1 | $101K | Buy |
|
|||||
|
2019
Q4 | $77K | Buy |
|
|||||
|
2019
Q3 | $89K | Buy |
|
|||||
|
2019
Q2 | $74K | Buy |
|
|||||
|
2019
Q1 | $62K | Sell |
|
|||||
|
2018
Q4 | $32K | Buy |
|
|||||
|
2018
Q3 | $40K | Buy |
|
|||||
|
2018
Q2 | $34K | Buy |
|
|||||
|
2018
Q1 | $33K | Buy |
|
|||||
|
2017
Q4 | $34K | Sell |
|
|||||
|
2017
Q3 | $48K | Buy |
|